Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares OutstandingShares OutstandingShares Repurchased
Ratios

Sensus Healthcare (SRTS) Short-Term Debt issuances (2017 - 2018)

Sensus Healthcare's quarterly Short-Term Debt issuances came in at -$4.2 million in Q3 2018, down 2468.33% year-on-year from $178000.0 in Q3 2017, and down 310.71% quarter-over-quarter from $2.0 million in Q1 2018.

Sensus Healthcare has reported Short-Term Debt issuances for 2 years, with the latest figure at -$4.2 million in Q3 2018.

  • For the quarter ending Q3 2018, Short-Term Debt issuances fell 2468.33% year-over-year to -$4.2 million; the trailing twelve-month figure through Dec 2018 stood at -$2.2 million (down 200.0% YoY), and the FY2018 full-year result was -$2.2 million, down 200.0% from the prior year.
  • Short-Term Debt issuances for Q3 2018 stood at -$4.2 million, down from $2.0 million in the prior quarter.
  • The five-year high for Short-Term Debt issuances was $2.0 million in Q1 2018, with the low at -$4.2 million in Q3 2018.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Short-Term Debt issuances (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 31.00 Mn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn -
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -1.23 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn -
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn -
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -1.00 Mn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 37.80 Mn
10 Sensus Healthcare 47.41 Mn 29.09 Mn - -

Historic Data

Download Data 🔒
DateValue
Sep 30, 2018 -4.22 Mn
Sep 30, 2018 -4.22 Mn
Mar 31, 2018 2.00 Mn
Mar 31, 2018 2.00 Mn
Dec 31, 2017 589,000.00
Dec 31, 2017 589,000.00
Sep 30, 2017 178,000.00
Sep 30, 2017 178,000.00
Jun 30, 2017 -52,030.00
Jun 30, 2017 -52,030.00
Mar 31, 2017 1.50 Mn
Mar 31, 2017 1.50 Mn